Study to Determine Interaction Between the Use of Feminizing Hormone Therapy and Antiretroviral Agents Concomitantly Among Transgender Women
CompletedOBSERVATIONAL
Enrollment
40
Participants
Timeline
Start Date
November 30, 2017
Primary Completion Date
October 1, 2019
Study Completion Date
October 1, 2019
Conditions
PrEP and ART
Trial Locations (1)
10330
The Thai Red Cross AIDS Research Centre, Ratchadamri
All Listed Sponsors
lead
Thai Red Cross AIDS Research Centre
OTHER
NCT03620734 - Study to Determine Interaction Between the Use of Feminizing Hormone Therapy and Antiretroviral Agents Concomitantly Among Transgender Women | Biotech Hunter | Biotech Hunter